chrisvoncsefalvay/vaers-outcomes huggingface dataset:
after waiting 15 minutes after the shot I started to walk out of the facility and felt light headed.  I wobbled back into the facility and fell to the floor.  I saw spot in my eyes and was extremely hot.   It appeared I passed out from the vaccine.  I was told after laying on the floor for a while I was a white as a ghost and sweating profusely. The brought a cold towel for my head and some juice, water, and food. after some time I was able to drink some juice and and eat some food.  After sitting in the lobby for some time I started to feel better and was able to leave.  I still have a light headed feeling, a little foggy on thoughts and a little dizzy.
brain fog; Body soreness; extreme tiredness; confusion; This is a spontaneous report from a non-contactable consumer (patient reported for self). A 27-year-old (non-pregnant) female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: unknown; lot unknown reason: unable to locate or read the details), via an unspecified route of administration, administered in arm Left on 11Oct2021 11:30 (at the age of 27 years old) as dose 1, single for covid-19 immunisation. The patient medical history was not reported. Known allergies were reported, depression. Concomitant medication(s) included influenza vaccine (FLU) on 01Nov2021 for immunisation. Other medications received in two weeks included Birth control, allergy medication, and anti-depress. Other medications received in 4 weeks included Flu shot. The patient received other vaccine in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced brain fog, body soreness, extreme tiredness, confusion on 11Oct2021. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any treatment for the events. The patient also received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: unknown; lot unknown reason: unable to locate or read the details), via an unspecified route of administration, administered in arm Left on 01Nov2021 12:30 (at the age of 27 years old) as dose 2, single for covid-19 immunisation. The outcome of the events (brain fog, body soreness, extreme tiredness, confusion) was reported as recovered (on an unspecified date in 2021).  The lot number for [BNT162B2], was not provided and will be requested during follow up.
Woke up super achy; 100.5 F fever; Chills; This is a spontaneous report from a contactable consumer (patient). A 27-years-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247; Expiration: Not provided) via unspecified route on 10Feb2021 at 02:45 PM (at 27-years-old) in the left arm as a single dose for COVID-19 immunization. Patient's medical history was not reported and no known allergies. Concomitant medications included Wellbutrin SR (bupropion hydrochloride) and Zoloft (sertraline hydrochloride). It was reported that the patient did not receive other vaccines with in 4 weeks. The patient did not have COVID-19 prior vaccination and not tested post vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot: EL3247; Expiry date: unknown) on 22Jan2021 via an unspecified route of administration in the left arm at SINGLE DOSE for COVID-19 Immunization. On 11Feb2021, the patient woke up super achy and with 100.5 F fever along with chills. Events were not treated. Outcome of events was resolving.
This spontaneous report as received from a physician refers to a 59 year old female patient with a positive history of herpes simplex. It was reported that the patient  had multiple (3 to 4) outbreaks per year (maximum of 7 under extremes of sun exposure or stress) since an unknown date, reported as since the age of 17. The patient did not have any outbreaks of shingles, but had chickenpox as a child at the age of 6 or 7 (date unspecified). The patient stated that the chickenpox was severe with whole body pocks, though no hospitalization, pneumonia, seizures or encephalitis was involved. The patient did not use any prophylactic medication, but she used acyclovir pills and acyclovir ointment as treatment for individual outbreaks of herpes simplex. She had never had a genital herpes outbreak. On an unknown date in 2013, the patient was vaccinated with a dose of ZOSTAVAX injection (dose, route of administration, lot # and expiry date were not reported). There were no concomitant therapies reported. The physician reported that the patient's herpes simplex cold sores did not return over the last two  years after the patients were vaccinated with ZOSTAVAX (onset date approximately in 2013). She had zero outbreaks since she had the vaccine. The patient stated that her sister-in-law had the same effect after her vaccination with ZOSTAVAX (captured in MARRS#1512USA001048). The physician stated that this occurrence might be "just a fluke" and there was no way of knowing the causality. All telephone attempts to obtain follow up information had been unsuccessful. This is one of two reports received from the same reporter. Additional information has been requested.
At 11:32 patient start to feel hot and clammy. Upon assessment patient began to slowly become unable to speak while seemingly losing consciousness. Patient's pulse began to drop. She was administered epinephrine 0.3mg at 11:33am in the right thigh and given a cold compress over forehead.  Within the following minute patient could sit up and became alert. Blood pressure was checked at 11:40 and was 112/66 with pulse of 55. She was now able to speak and state her name, where she was, etc. Ambulance arrived and completed assessment. Patient refused transport to hospital and was able to walk out of the pharmacy. She called a couple of hours later and stated that she was feeling much better and back to herself.
Patient reported a swollen tongue, sores/ulcers in her mouth and under her tongue, symptoms consistent with thrush (all improved within a few weeks), and dry mouth symptoms that had never occurred before that are still on going.
Patient experienced chills, fever and swelling in arm within 24 hours of vaccination. Resolved by 6/7/04. No treatment. Patient reported above on 6/7/04.
Patient reported that she started feeling tired after she received the vaccine. The next day she started having chills, nausea, and diarrhea. On February the 16th she started vomiting.
Patient called pharmacy about two weeks after immunization and complained that she had experienced pain during the vaccination and had a bruise about one inch in diameter two weeks later.
m.d. rpt pt recv vax in 1/96 & in 1998 lab evaluation revealed a lack of response
1st dose on 27-SEP-2019 2nd dose on 17-MAY-2022; During administration the patient move the arm so it was not a complete dose; This case was reported by a physician via call center representative and described the occurrence of drug dose administration interval too long in a 60-year-old female patient who received Herpes zoster (Shingrix) (batch number 5A9GE, expiry date 3rd June 2023) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 27th September 2019, batch number KJ9N5, expiry date 17th October 2021).   On 17th May 2022, the patient received the 2nd dose of Shingrix. On 17th May 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long and incomplete dose administered. On an unknown date, the outcome of the drug dose administration interval too long and incomplete dose administered were unknown.   Additional Information: GSK Receipt Date: 17-MAY-2022 Reporters comment: The patient received 2nd dose of Shingrix in an unknown arm. The patient received 2nd dose of Shingrix late but during the administration, the patient moved the arm, so it was not a complete dose. The reporter consented to follow up. Additional supportive information: The patient received 2nd dose of Shingrix, later than the recommended schedule, which led to lengthening of vaccination schedule but during the administration, the patient moved the arm, so it was not a complete dose, which led to incomplete dose administered.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022079744:Same Reporter
103 degree fever that resolved 5/9/10, joint pain, achiness, swollen neck glands anterior and posterior that continues today. Client is unable to go to work today due to pain. Instructed client to contact her MD for follow-up and medical exemption for 2nd MMR.
Chills, pain in all joints, very severe headache, temp over 103 and  Frightening irregular heart beat. Next day felt better but experienced phantom smells for over 5 months numerous times a day
difficulty breathing; heart hurts; muscle pain; joint pain; fever; rash develop on her her arm and going to her lower extremities; This spontaneous case was reported by a health care professional and describes the occurrence of DYSPNOEA (difficulty breathing), CHEST DISCOMFORT (heart hurts), RASH (rash develop on her her arm and going to her lower extremities), MYALGIA (muscle pain) and ARTHRALGIA (joint pain) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced RASH (rash develop on her her arm and going to her lower extremities). On an unknown date, the patient experienced DYSPNOEA (difficulty breathing), CHEST DISCOMFORT (heart hurts), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and PYREXIA (fever). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and CORTISONE at an unspecified dose and frequency. At the time of the report, DYSPNOEA (difficulty breathing), CHEST DISCOMFORT (heart hurts), RASH (rash develop on her her arm and going to her lower extremities), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Sore arm day of vaccination and continued soreness. Increased pain recently 11/15/2021. More troublesome at night; causes wakening up 2-3 times a night. Occasionally cannot lift arm up. Medical diagnosis of a nerve hit during vaccination.
pt returned on 15jul98 complaining of headache that began immed p/inject. an hour p/inject pt had diarrhea lasting all night
Began to feel bad one week after receiving injection and made appt with provider,   xray showed infiltrate, pnuemonia, in right lower lobe, antibiotics prescribed and taken increased  shortness of breath at time of visit.
Pt recvd vax 25SEP91 & on 29SEP91 blood platelets dec 25,000; referred to hosp 30SEP91; pt admitted platelets dec 14,000; pt d/c 2OCT91 platelets 49,000;
I took the Prevnar 20 INJ 0.5ml on 04/3/2023 and i developed a rash that is 6x10in size. The rash is hot and raised, i had to go to doctor and was prescribed antibiotics and must take Benadryl.
Information has been received from a physician concerning a 17 year old female who on 25-MAY-2007 was vaccinated with the first dose of GARDASIL (lot# 656051/0244U). On 27-JUL-2007 the patient was vaccinated with the second dose of GARDASIL (lot# 658100/0525U). On 27-NOV-2007 the patient was vaccinated with the third dose of GARDASIL (lot# 655327/1287U). On 08-May-2008 the office manager reported that the patient experienced pain and decreased movement in the injection site arm on the same day of vaccination with the third dose of GARDASIL, 27-NOV-2007. The patient was seen in the office on 20-DEC-2007 and was referred to a neurologist (outcome unspecified). On 08-May-2008, the office manager reported that the patient was still having pain in the injection site arm, but it was improving. The arm had no redness, no numbness, no tingling or masses and the arm had normal capillary appearances. A scar was noted (not clear if the scar was related to vaccination). There was no other information to report. Additional information has been requested.
HEAD ACHE AND LOW GRADE FEVER WITHIN 24 HOURS OF VACCINATION.  ORAL TEMP 101.5 F.  I ALSO DEVELOPED A PRODUCTIVE COUGH AND STUFFED SINUSES
Vaccine was expired for 19 days. Given inadvertently due to confusion in extended dates. Vaccine stored in refrigerator and not ultra-cold. Used ultra-cold extended date instead of 10 week expiration date.
15 minutes after vaccine administration, patient presented to EC complaining of chest pressure, palpitations, lightheadedness and feeling faint. Patient's symptoms resolved by 4:15pm. Patient was prescribed Benadryl 50mg PO and PEPCID 40mg PO. Patient discharged from EC home at 6pm.
weird tingling in her mouth.; Within 25 minutes, the numbness and tingling had spread to her face and behind her ear.; symptoms were on both sides of her face.; This spontaneous case was reported by a physician and describes the occurrence of PARAESTHESIA ORAL (weird tingling in her mouth.), HYPOAESTHESIA (Within 25 minutes, the numbness and tingling had spread to her face and behind her ear.) and VACCINATION COMPLICATION (symptoms were on both sides of her face.) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced PARAESTHESIA ORAL (weird tingling in her mouth.), HYPOAESTHESIA (Within 25 minutes, the numbness and tingling had spread to her face and behind her ear.) and VACCINATION COMPLICATION (symptoms were on both sides of her face.). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PARAESTHESIA ORAL (weird tingling in her mouth.), HYPOAESTHESIA (Within 25 minutes, the numbness and tingling had spread to her face and behind her ear.) and VACCINATION COMPLICATION (symptoms were on both sides of her face.) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.
fever; This case was reported by a other health professional via interactive digital media and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 17th June 2020, the patient received Shingrix. On 17th June 2020, less than a day after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was not reported but was selected as per the vaccine indication. On 17th June 2020 at 4.16. 14 AM, the patient experienced fever after receiving the Shingrix vaccine. The patient asked, how long the fever would have.
Prolonged Pain at injection site, unable to raise arms without pain, difficulty lifting lightweight items, felt like intense muscle bruise, no visible bruise, pain in left arm lasted 11 months, pain in right arm lasted 7 months.
Red, itchy, warm to touch   Used Benadryl spray & ice First day with symptoms so not sure of outcome
malaise; cough; This is a spontaneous report received from a contactable other healthcare professional. A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Four days after the patient's COVID-19 vaccine (unspecified date), the patient started experiencing malaise and cough. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
DTAP given 01/15/04.  Went to ER on 01/17/04 with complaint of left thigh with "large erythema, mild swelling (+) warmth". Recommended to give Aelone 1 tsp per mouth every day, ice, Benadryl as needed.
On 02/12/2021 around 11:00am I was assigned to have Covid 19 shot at the table#6. At that time I saw the Vaccine was already in the syringe which was in the plastic bag with zipper. Ten days after the shot I felt well, no pain nor swell on my left shoulder. But in the morning of 02/23/2021 after waking up I started to feel hurt to my left arm and the pain was transmitted to the left of my back (left lung). During these 3 days 23,24,25 my pain reached the maximum intensity 10/10 even I took 3 times a day Ibuprofen which was each time 2x200mg. On 02/26/2021 I went to Hospital in the Emergency Unit and after diagnosis the Doctors found that I had 3 heart arteries clog-up. How can I be sure that the liquid in the syringe is the Pfizer Vaccine or something else? I used to see the TVs broadcast on the Covid 19 shot that the nurse inserts the syringe in the small Pzifer bottle, suck the Vaccine into syringe and inject  the vaccine into the shoulder of the patient. Can CDC require that all Covid 19 providers show the vaccine to all patients before the shot? In 2017 I had an Angiogram and my 3 bypasses were not clogged why they are all clogged now? I don't change my every day diet and I'm very careful with eating fat, cholesterol and salt in my everyday food.
COVID infection following COVID vaccine series 02/04, Pfizer, dose#1 02/25, Pfizer, dose #2 12/27 COVID swab, result: detected 12/25 pt cc: rhinorrhea exposure: unknown
Pt recieved second dose of Moderna and reported feeling dizzy  at 8:30 am while waiting the 15 minute wait time in the biosafety area. BP 110/62 and pulse 60, respirations 18. Pt was observed for about 15 minutes until she felt better and went home.
per report , pt received Prevnar (not clear if Prevnar 13 or 20) on 7/28 woke up Saturday 7/30 with visual disturbances, rash, nausea/vomiting
Left thigh 10 mm X 8 mm red, inflamed, warm to touch.
Patient got so sick; Initial information received on 18-Nov-2020 regarding an unsolicited valid non-serious case from a consumer/non-health care professional via social media.  This case involves patient of (Unknown demography) who got so sick (illness), after receiving INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.   On an unknown date (about 5 years ago), the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site. for prophylactic vaccination.  On an unknown date, the patient developed non-serious sickness (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of reports, the outcome was not reported for the event illness.  There will be no information on the batch number for this case.
This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown age/gender. The patient's concurrent or historical conditions were not provided. Concomitant therapies were not reported. On an unknown date the patients were vaccinated with improperly stored LIQUID PEDVAXHIB (dose, frequency and route were not reported). No adverse effects were reported and no product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
I received the Moderna vaccine. I had and still have a very sore arm (day 1 into day 2). My arm and body was fine, but my arm progressively got worse throughout the day. My throat later the evening of day 1 was severely dry. It felt as though I had cotton balls in my throat, so I chugged as much water as I could until my throat was lubricated enough.
Patient said she had pain in her shoulder shortly after receiving the vaccine and that it "feels like I'm getting stabbed with a needle when I move my arm." There is a knot in her arm where the shot was given that seems low on the deltoid muscle.
The staff made appt, received consent from the POA, presented a card with 2 doses, upon entry to IMMPACT a dose has previously been administered on 11/7/2021. This was confirmed had administered but staff at the facility did not record.
swelling-redness around site-crying all noc-rash; treated w/DPh;
Itchy scalp at beginning. Rash started on shoulders, now moved mostly on back.
arm swollen, shooting pain down to fingers, red welts on chest, breast, arm, hot to touch;ice, APAP q 4hr-72 hr duration;
Received pneumococol shot in right arm, also same arm for wife. Area swelled up and became extremely, extremey painful to the touch. Neither of us could sleep that night, and swellig moved around to different areas of arm. It Is only today Sunday 10/5/2014 that the pain and swelling are going down. We should have gone to the ER but didn't vaccine # PPV23.
Vaccine given to 17 year old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine given to 17 year old) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024C21A and 038C21A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine given to 17 year old). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine given to 17 year old) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided by the reporter.
7/21/2005 Pt came to office with c/o rash 4-5 days post MMR and VAR. Getting better. Low grade temp, more erythematous after bath. Classic macular papular rash on torso/face no involvement of palms or soles of feet.